|
Alexza Pharmaceuticals, Inc. (ALXA) Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Thursday, July 24, 2008
More...
|
Poniard Pharmaceuticals, Inc. (PARD) to Host Second Quarter 2008 Financial Results Conference Call on July 31
Thursday, July 24, 2008
More...
|
Progen Pharmaceuticals Limited (PGLA) Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A
Thursday, July 24, 2008
More...
|
Cornerstone Pharmaceuticals Announces Approval to Conduct Phase I/II Clinical Trial of CPI-613 in Cancer Patients by FDA
Thursday, July 24, 2008
More...
|
Sagent Pharmaceuticals, Inc. Launches Ceftazidime for Injection, USP
Thursday, July 24, 2008
More...
|
The New England Journal of Medicine Publishes Bayer HealthCare Pharmaceuticals (BAY)' Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
Thursday, July 24, 2008
More...
|
Caraco Pharmaceutical Laboratories, Ltd. (CPD) Announces Resignation from Board of Directors of Jitendra Doshi and Appointment of GP Singh Sachdeva
Thursday, July 24, 2008
More...
|
Panacos Pharmaceuticals Inc. (PANC) to Report Second Quarter Results and Provide Development Update
Thursday, July 24, 2008
More...
|
Frost & Sullivan Release: Novel Drug Delivery Mechanisms Offer Significant Potential for the European Pharmaceutical Industry
Thursday, July 24, 2008
More...
|
Anadys Pharmaceuticals, Inc. (ANDS) to Report Second Quarter 2008 Financial Results
Thursday, July 24, 2008
More...
|
AVANIR Pharmaceuticals (AVNR) Invites Investors to Third Quarter Conference Call
Thursday, July 24, 2008
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Announces Second Quarter 2008 Financial Results
Thursday, July 24, 2008
More...
|
Momenta Pharmaceuticals, Inc. (MNTA) Appoints Bruce A. Leicher as General Counsel
Thursday, July 24, 2008
More...
|
Genesis Pharmaceutical, Inc. Announces New Board Member and Forms Committees
Thursday, July 24, 2008
More...
|
Momenta Pharmaceuticals, Inc. (MNTA) Reports Financial Results for the Second Quarter of 2008
Thursday, July 24, 2008
More...
|
|